Spero Therapeutis prices IPO at $14, low end of range

|About: Spero Therapeutics, Inc. (SPRO)|By:, SA News Editor

Spero Therapeutics (Pending:SPRO) has priced its initial public offering to the low end of its range, at $14.

It had marketed at $14-$16/share. It's offering 5.5M common shares at that price, for a raise of $77M.

Underwriters have a 30-day option to buy up to 825,000 more shares at the IPO price.

It will start trading on Nasdaq tomorrow.

Update: Shares opened at $13.25, ~5% lower than the offer price of $14.

Subscribe for full text news in your inbox